Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.

Clinical rheumatology - 1 Dec 2010

Nakamura Tadashi, Higashi Syu-ichi, Tomoda Kunihiko, Tsukano Michishi, Shono Masahiro

Abstract excerpt

The benefit of biological therapies in rheumatoid arthritis (RA) treatment is well known, but their role in amyloid A (AA) amyloidosis secondary to RA is unclear. The aim of this study was to clarify the clinical benefit of etanercept in RA patients with AA amyloidosis. We treated 14 RA patients who had serum amyloid A protein (SAA) 1.3 allele, with biopsy-confirmed AA amyloidosis with etanercept and investigated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloidosis
Share to Anti-Inflammatory Agents, Non-Steroidal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Arthritis, Rheumatoid

Share to Etanercept

Share to Immunoglobulin G

Share to Receptors, Tumor Necrosis Factor

Share to Renal Insufficiency

Share to Serum Amyloid A Protein

Source

Identifiers

PMID: 20440529
DOI: 10.1007/s10067-010-1469-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.PMID 20440529Read ↗

Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis.Semantic proximity Read ↗

Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.Semantic proximity Read ↗

The evolving spectrum of kidney amyloidosis: advances in diagnosis, typing and treatmentSemantic proximity Read ↗

Nephrotic Range Proteinuria and Restrictive Heart Failure in a Patient with Secondary Amyloidosis: A Case ReportSemantic proximity Read ↗

Inflammatory bowel disease and systemic AA amyloidosis.Semantic proximity Read ↗

Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome.Semantic proximity Read ↗

Ageing: a risk factor for amyloid A amyloidosis in rheumatoid arthritis.Semantic proximity Read ↗

Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis.Semantic proximity Read ↗

Measurement of serum amyloid A1 (SAA1), a major isotype of acute phase SAA.Semantic proximity Read ↗

Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.Semantic proximity Read ↗

Mathematical Modeling of AA Amyloidosis: Coupling SAA-HDL Binding Dynamics with Path-Dependent Renal AgingSemantic proximity Read ↗

End-stage renal failure due to transthyretin amyloidosis after liver transplantation: outcomes in 19 registry cases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.